New NHL Therapy Yields Promising Results   Leave a comment

Researchers at the Stanford University School of Medicine have discovered an antibody-combination therapy that eliminates NHL in mice. There are two antibodies involved in this treatment: 1) rituximab, an organic compound already used to treat NHL, and 2) an antibody that blocks the ability of specific surface molecules on cancer cells. Combined, these two antibodies cured cancer in over 60% of the study subjects. With results as promising as these, human trials are expected to begin in the near future.

The truly remarkable aspect of this therapy is that it involves no radiation or chemotherapy. Essentally, these antibodies enable the patient’s immune system to systematically target and kill cancer cells. To read more about this exciting research, click here.


Posted September 5, 2010 by lymphomactivist in Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: